- Remove this product from my favorite's list.
- Add this product to my list of favorites.
Products
Newsletter
Background
Glypican 1 has been shown to interact with SLIT2. This protein is involved in the misfolding of normal prion proteins in the cell membrane to the infectious prion form. Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation.
Source
Recombinant Human Glypican 1, His Tag (GP1-H52H9) is expressed from human 293 cells (HEK293). It contains AA Asp 24 - Ser 530 (Accession # P35052-1).
Predicted N-terminus: Asp 24
Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 58.0 kDa. The protein migrates as 60 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 1.0 EU per μg by the LAL method.
Purity
>85% as determined by SDS-PAGE.
Formulation
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 150 mM NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
Bioactivity
Please refer to product data sheet.
(1) "Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma"
Sun, Cao, Okada et al
J Immunother Cancer (2023) 11 (1)
(2) "Pharmacokinetics and Biodistribution of 89Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma"
Ghosh, Fletcher, Huda et al
Mol Pharm (2023)
(3) "Enhancing anti-tumor efficacy and immune memory by combining 3p-GPC-3 siRNA treatment with PD-1 blockade in hepatocellular carcinoma"
Shao, Yu, Han et al
Oncoimmunology (2022) 11 (1), 2010894
Showing 1-3 of 1548 papers.
Recombinant Human Glypican 3 / GPC3 Protein, low endotoxin, His tag, 100 µg - 416,00 €
Recombinant Cynomolgus Glypican 3 / GPC3 Protein, His Tag, 100 µg - 585,00 €
Recombinant Mouse Glypican 3 / GPC3 Protein, His Tag, 100 µg - 416,00 €
Recombinant Mouse Glypican 1 / GPC1 Protein, His Tag, 100 µg - 455,00 €
Recombinant Cynomolgus Glypican 3 / GPC3 Protein, Llama IgG2b Fc Tag, low endotoxin, 100 µg - 455,00 €
Welcome Login
Contact us
Follow us